FDA warns against use of kratom

11:25 EST 14 Nov 2017 | Healio

Scott Gottlieb
The FDA issued a warning today about the potentially fatal risks linked to kratom, a plant-based product from Asia that the agency said is used to treat medical conditions such as pain, anxiety and depression, and used recreationally for its euphoric effects.
“I want to be clear on one fact: There are currently no FDA-approved therapeutic uses of kratom. Moreover, the FDA has evidence to show that there are significant safety issues associated with its use,” FDA Commissioner Scott Gottlieb, MD, said in a statement, adding that kratom’s effects mirror those of

Original Article: FDA warns against use of kratom


More From BioPortfolio on "FDA warns against use of kratom"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...